Although the transcription factor c-Myc is essential for the establishment of a metabolically active and proliferative state in T cells after priming, its expression is transient. It remains unknown how T cell activation is maintained after c-Myc expression is downregulated. Here we identified AP4 as the transcription factor that was induced by c-Myc and sustained activation of antigenspecific CD8 + T cells. Despite normal priming, AP4-deficient CD8 + T cells failed to continue transcription of a broad range of c-Myc-dependent targets. Mice lacking AP4 specifically in CD8 + T cells showed enhanced susceptibility to infection with West Nile virus. Genome-wide analysis suggested that many activation-induced genes encoding molecules involved in metabolism were shared targets of c-Myc and AP4. Thus, AP4 maintains c-Myc-initiated cellular activation programs in CD8 + T cells to control microbial infection.
Protective immunity by CD8 + T cells is critical for host defense against many pathogens that cause death or chronic infection. During acute infection by a virus or intracellular bacterium, antigen-specific CD8 + T cells are primed by signaling via the T cell antigen receptor (TCR), costimulatory molecules and cytokine receptors and undergo rapid population expansion, effector differentiation and memory cell formation 1, 2 . In the priming phase, an activated CD8 + T cells becomes larger by increasing global gene transcription and protein translation and uses aerobic glycolysis pathways to produce the energy and materials needed for biosynthesis before entry into the cell cycle [3] [4] [5] [6] [7] .
Published studies have established that the transcription factor c-Myc is essential for the initiation of the global cellular activation processes in activated lymphocytes as well as in cancer and embryonic stem cells [8] [9] [10] [11] . Expression of c-Myc is induced by signaling through the TCR and the receptor for interleukin 2 (IL-2R) 12 , and c-Myc is essential for the metabolic reprogramming and growth of T cells 13 .
During acute infection, the population expansion of CD8 + T cells persists even after levels of antigen and inflammation wane 4 . While this persistent proliferation may be driven by residual antigen on antigenpresenting cells, other evidence suggests that optimally primed CD8 + T cells continue to proliferate after antigen and cytokines decrease to suboptimal concentrations [14] [15] [16] [17] . The expression of c-Myc is rapidly induced in activated T cells 9, 13 . Its expression, however, does not persist throughout the duration of T cell population expansion 9, 18 . These findings suggest that other transcription factors maintain c-Myc-initiated cellular activation to maximize the clonal expansion and effector differentiation of T cells during acute responses to pathogen infection.
We hypothesized that signaling via the TCR and cytokine receptors during the early stage of pathogen infection induces transcription factors that program CD8 + T cells for a durable response. Among the cytokines established as being important for CD8 + T cell responses, IL-2 sustains clonal expansion in vitro and possibly in vivo [19] [20] [21] and promotes effector differentiation 20, 22, 23 . In this study, we identified AP4 as a transcription factor regulated by IL-2R signaling and demonstrated that AP4 sustained the proliferation of antigen-specific CD8 + T cells in a cell-autonomous way in models of acute infection. CD8 + T cells from mice lacking AP4 were able to initiate rapid clonal expansion similar to that of cells from age-matched wild-type mice but failed to sustain the rapid clonal expansion rates of wild-type cells, which led to a much lower clonal frequency at the peak of response. Control of infection with West Nile virus (WNV) in the central nervous system (CNS), which requires sustained antigen-specific CD8 + T cell responses for host-mediated clearance and survival, was compromised in mice lacking AP4 specifically in CD8 + T cells. Finally, our data suggested that AP4 sustained cellular activity through the regulation of a substantial proportion of genes that are targets of c-Myc. Thus, our data establish that AP4 regulates the magnitude of acute responses by CD8 + T cells to control microbial infection.
RESULTS

Regulation of AP4 by signaling via the TCR and IL-2R
By microarray analysis, we identified ~70 transcription factor-encoding genes whose expression changed more than 1.8-fold in CD8 + T cells following neutralization of IL-2 (Fig. 1a) . In addition to known IL-2-regulated genes such as Bcl6 and Eomes 23 , we identified Tfap4 (which encodes AP4) as a gene dependent on signaling via IL-2R (Fig. 1a) . AP4 is a basic helix-loop-helix protein that regulates the transcription of viral genes and repression of the gene encoding the monomorphic coreceptor CD4 (Cd4) [24] [25] [26] . Although expression of Tfap4 mRNA was reduced modestly upon withdrawal of IL-2, expression of AP4 protein was substantially diminished (Fig. 1b,c) , which suggested that sustained AP4 expression required IL-2R signaling at both the transcriptional level and post-transcriptional level. The expression of AP4 from a retrovirus also required the stimulation of cells via IL-2R ( Fig. 1d) , which suggested its expression was regulated predominantly at the post-transcriptional level. The half-life of AP4 protein was 2-3 h under permissive conditions (with the addition of IL-2) or nonpermissive conditions (neutralization of IL-2) ( Fig. 1e) , with its degradation mediated by the ubiquitin-proteasome pathway (Fig. 1f) . AP4 expression was sustained by TCR stimuli or other γ-chain cytokines (IL-7 and IL-15) but not by IL-12 or type I interferons (Fig. 1g) . These results suggested that a common pathway converging from signaling via the TCR and IL-2Rγ chain sustained the expression of AP4 protein. Consistent with that, inhibitors of the mitogen-activated protein kinases MEK and p38 (U0126 and SB203580, respectively) attenuated the accumulation of AP4 protein in the presence of stimulation via the TCR or IL-2R ( Fig. 1h) . To confirm the roles of the TCR and IL-2R in maintaining AP4 expression in vivo, we obtained naive CD8 + T cells from P14 mice 27 , which express a transgene encoding a TCR of -chain variable region 2 and -chain variable region 8 (V  2 + V  8 + TCR) specific for the epitope of amino acids 33-41 of lymphocytic choriomeningitis virus (LCMV) glycoprotein (gp (33) (34) (35) (36) (37) (38) (39) (40) (41) ), then adoptively transferred those cells into wild-type host mice and acutely infected the host mice with the Armstrong strain of LCMV (LCMV-Arm) and assessed AP4 in the P14 cells. We found that the adoptively transferred LCMV-gp-specific P14 T cells had high expression of AP4 protein on days 4 and 5 after infection; this expression decreased on days 6 and 7 as T cell population expansion slowed markedly ( Fig. 1i) . In activated CD8 + T cells on day 4.5 after infection with LCMV-Arm, we detected AP4 protein specifically in CD25 hi cells but not in CD25 lo cells, despite the similar abundance of Tfap4 mRNA in both subpopulations (Fig. 1j ). Furthermore, P14 T cells lacking the gene encoding IL-2R (Il2ra −/− cells) had lower expression of AP4 protein than did their Il2ra +/+ counterparts at 4 d after infection with LCMV-Arm ( Fig. 1k) . We concluded that AP4 was regulated posttranscriptionally in CD8 + T cells via signaling through the TCR and IL-2R in vitro and in vivo.
CD8 + T cell population expansion requires AP4
To assess the functions of AP4 in immune responses, we infected AP4-deficient (Tfap4 −/− ) and congenic wild-type C57BL/6 mice with LCMV-Arm and examined the population expansion and differentiation of CD8 + T cells. At the peak of the response, the abundance of total CD8 + T cells and KLRG1 + terminally differentiated CD8 + T cells 1 was ~70% lower and 90% lower, respectively, in Tfap4 −/− mice than in wild-type mice ( Fig. 2a,c) . The abundance of T cells specific for gp (33) (34) (35) (36) (37) (38) (39) (40) (41) was also 80% lower in Tfap4 −/− mice than in wild-type mice and, among those cells, the abundance of KLRG1 + effector cells was (a) Microarray analysis of transcription factor-encoding genes with a difference in expression of >1.8-fold in activated CD8 + T cells treated for 12 h with IL-2 (100 U/ml; + IL-2) relative to their expression in activated CD8 + T cells treated for 12 h with anti-IL-2 (2 µg/ml; -IL-2); results are presented as mean signal intensity. (b) Quantitative RT-PCR analysis of Eomes, Tfap4 and Bcl6 in CD8 + T cells treated as in a; results for cells treated with IL-2 are presented relative to those of cells treated with anti-IL-2, set as 1 (dashed line). (c) Immunoblot analysis of AP4 in CD8 + T cells before treatment (Pre) or treated as in a; phosphorylated STAT5 (p-STAT5) and -tubulin serve as loading controls. (d) Immunoblot analysis of AP4 in Tfap4 −/− CD8 + T cells transduced with retrovirus (RV) containing an empty vector (EV) or vector expressing AP4 (above blot) and treated as in a (above lanes); the histone deacetylase HDAC1 serves as a loading control throughout. (e) Immunoblot analysis of AP4 in CD8 + T cells treated for 0-9 h (above lanes) with IL-2 or anti-IL-2 (above blot) in the presence of cycloheximide (10 µM diminished by 90% ( Fig. 2b,d) .
To determine whether the requirement for AP4 was intrinsic to CD8 + T cells, we deleted a loxP-flanked Tfap4 allele (Tfap4 F ) specifically in CD8 + T cells with Cre recombinase transgenically expressed under the control of regulatory elements of the gene encoding CD8 that are active in post-selection thymocytes (CD8-Cre) 28 ( Supplementary Fig. 1a,b) . We observed a similar reduction in the number of total, KLRG1 + and gp(33-41)-specific CD8 + T cells in Tfap4 −/− and Tfap4 F/F CD8-Cre + mice relative to their abundance in wild-type mice ( Supplementary Fig. 1c,d) , which indicated that the requirement for AP4 was intrinsic to CD8 + T cells. The clonal expansion and effector differentiation of CD8 + T cells also were reduced in Tfap4 −/− mice infected with Listeria monocytogenes expressing ovalbumin (LM-OVA) relative to that in wild-type mice ( Supplementary  Fig. 2a,b) . Memory cells were generated and maintained similarly in Tfap4 −/− , Tfap4 F/F CD8-Cre + and wild-type mice following infection with LCMV-Arm or LM-OVA ( Supplementary Fig. 3a-d) . However, the population expansion of Tfap4 −/− and Tfap4 F/F CD8-Cre + memory T cells was diminished relative to that of their wild-type counterparts upon secondary challenge ( Supplementary Fig. 3e-h) . Thus, AP4 was essential for the population expansion of antigen-specific CD8 + T cells both in primary responses and recall responses.
AP4 sustains CD8 + T cell clonal expansion
To compare the population expansion of Tfap4 −/− and wild-type CD8 + T cells in an identical environment, we generated Tfap4 −/− mice of the P14 mouse strain 27 . We mixed V  2 + V  8 + naive CD8 + T cells from Tfap4 −/− (Thy-1.2 + CD45.2 + ) P14 mice and Tfap4 +/+ (Thy-1.1 + CD45.2 + ) P14 mice at a ratio of 1:1 and adoptively transferred the mixture into congenic wild-type (CD45.1 + ) host mice. Prior to infection with LCMV-Arm, the ratio of Tfap4 −/− P14 T cells to Tfap4 +/+ P14 T cells remained approximately 1:1 in the spleen (Fig. 3a) . That result was consistent with the similar frequency of CD8 + T cells in various tissues of Tfap4 −/− and wild-type mice under steady-state conditions (Fig. 3b) . To determine whether AP4 was required for the initial proliferation of P14 T cells, we labeled Tfap4 −/− and Tfap4 +/+ P14 donor T cells with the division-tracking dye CFSE, then adoptively transferred the cells into wild-type (CD45.1 + ) host mice and infected the host mice with LCMV-Arm. On day 3 after infection, both Tfap4 −/− P14 T cells and Tfap4 +/+ P14 T cells diluted CFSE to an undetectable level ( Fig. 3c) , consistent with the similar number of P14 T cells in the spleen and the frequency of cells positive for the thymidine analog BrdU following pulse labeling ( Fig. 3d-g) . These results established that AP4 was dispensable for the initial proliferation of CD8 + T cells during the antigen-specific response. Despite their rapid early population expansion, the absolute number of Tfap4 −/− P14 donor cells was much lower than that of Tfap4 +/+ P14 donor cells at the peak of the response ( Fig. 3d-f ). Although Tfap4 −/− P14 cells continued to proliferate until day 7 after infection, they failed to maintain rapid proliferation rates, as judged by BrdU pulse labeling on day 4 and later ( Fig. 3g ). Because CD8 + T cells divide six to seven times per day during a response to acute infection 29 , the effect of a mild but continued decrease in the rate of incorporation of BrdU could theoretically result in a reduction in the clonal expansion of Tfap4 −/− donor cells of over 90% compared with that of Tfap4 +/+ P14 donor cells over 4 d ( Fig. 3e,g) . We also observed reduced clonal expansion, incorporation of BrdU and activation of the metabolic checkpoint kinase mTOR pathway in Tfap4 −/− OT-I T cells (which have transgenic expression of an ovalbumin-specific TCR) following infection with LM-OVA ( Supplementary Fig. 2c-e ). We did not, however, observe a difference between Tfap4 −/− P14 T cells and Tfap4 +/+ P14 T cells in the frequency of annexin V-binding cells in those populations on day 6 ( Fig. 3h,i) or in the ratio of Tfap4 −/− P14 T cells to Tfap4 +/+ P14 T cells in various compartments on day WT Tfap4 ( npg 7 after infection of the host with LCMV-Arm ( Fig. 3j) . These results suggested no substantial difference in the apoptosis or trafficking of antigen-specific T cells in vivo. Furthermore, it was unlikely that AP4 regulated the sensitivity of the TCR itself, since Tfap4 −/− and Tfap4 +/+ OT-I T cells proliferated at similar rates and produced interferon-γ at similar frequencies in response to stimulation with the OVA peptidepulsed irradiated wild-type splenocytes in vitro ( Supplementary  Fig. 2f-h) . However, Tfap4 −/− cells were outcompeted (in number) by Tfap4 +/+ cells during coculture, and Tfap4 −/− cells failed to blast when incubated for 4 d or longer with irradiated splenocytes pulsed with 0.1 nM OVA peptide ( Supplementary Fig. 2f-h) . These results suggested that AP4 was required for sustained proliferation of T cells after stimulation of the TCR.
Protection against infection with WNV requires AP4
We next assessed the contribution of AP4 to CD8 + T cell-mediated protection against a lethal infection in a model of infection with WNV. WNV is a virulent zoonotic virus that causes fatal encephalitis in humans and mice 30, 31 . CD8 + T cells are required for the clearance of WNV in both the spleen and the CNS 32 . To determine whether AP4 was required for protection against infection with WNV in a CD8 + T cell-dependent manner, we infected Tfap4 F/F CD8-Cre + mice and age-matched control Tfap4 F/F Cre − mice with WNV. While the majority of Tfap4 F/F Cre − mice survived the infection, all Tfap4 F/F CD8-Cre + mice died between days 8 and 13 (Fig. 4a) , similar to the death of WNV-infected mice lacking CD8 + T cells 32 . Tfap4 F/F CD8-Cre + mice sustained higher viral loads in the brain than those of age-and sexmatched Tfap4 F/F Cre − mice on day 9 after infection ( Fig. 4b) , which indicated that AP4 expression in CD8 + T cells was essential for the control of WNV in the CNS. The population expansion of CD8 + T cells specific for the WNV nonstructural protein NS4B was diminished in WNV-infected Tfap4 −/− and Tfap4 F/F CD8-Cre + mice compared with that of WNV-infected age-and sex-matched wild-type mice in the spleen on day 7 after infection ( Supplementary Fig. 4 ). However, npg A r t i c l e s AP4 was dispensable for control of WNV in the spleen (Fig. 4c) .
Consistent with that observation, we detected no difference in burden of LCMV-Arm or LM-OVA in peripheral tissues following infection ( Fig. 2e and Supplementary Fig. 2i) , presumably because clearance of these pathogens begins at an early phase of the acute response. In contrast, AP4 was required for host protection against infection with WNV in the CNS (Fig. 4a,b) , and AP4-mediated sustained activation of antigen-specific CD8 + T cells may be critical for control of certain CNS pathogens.
AP4 sustains T cell activation
When T cells are primed, c-Myc activates aerobic glycolysis and amplifies global gene transcription and protein synthesis, which leads to cell growth and metabolic reprogramming 6, 9, 13, 33 . The expression of c-Myc was induced rapidly after stimulation of the TCR, followed by upregulation of AP4 expression in CD8 + T cells (Supplementary Fig. 5a,b) . c-Myc was essential for the upregulation of AP4 expression in activated CD8 + T cells, at the level of both protein and mRNA (Fig. 5a) . In agreement with a published study 34 , c-Myc bound to the Tfap4 locus in activated CD8 + T cells (Supplementary Figs. 5c and 6e) , which further suggested that AP4 expression was augmented by c-Myc through direct binding. In contrast to the defective growth and metabolic changes of Myc-deficient T cells 13 , activated Tfap4 −/− CD8 + T cells underwent normal blast development accompanied by active glycolysis in vitro ( Supplementary  Fig. 5d-f) . Moreover, Tfap4 −/− and Tfap4 +/+ OT-I or P14 T cells were of similar size 3 d after infection with LCMV-Arm or LM-OVA ( Fig. 5b and Supplementary Fig. 5g ). The differences between Tfap4 −/− and wild-type CD8 + T cells in their gene expression either 3 d after activation in vitro or 2 d after infection with LM-OVA were substantially smaller than those observed at later time points, with alteration of few genes relevant to T cell activation (Supplementary Fig. 5h ). Thus, AP4 was dispensable for establishment of the c-Myc-dependent cellular response to T cell activation. However, at later time points (days 4 and 6), Tfap4 −/− OT-I or P14 T cells were smaller than their Tfap4 +/+ OT-I or P14 counterparts activated in the same host mice (Fig. 5b,c and Supplementary Fig. 5g) . The difference between Tfap4 −/− cells and control cells in terms of size coincided with the downregulation of c-Myc expression in antigen-specific CD8 + T cells after infection with LM-OVA ( Fig. 5d,e) . A small fraction of OT-I T cells primed by infection of the host with LM-OVA upregulated c-Myc protein, as determined with a knock-in allele encoding a fusion of c-Myc and green fluorescent protein (c-Myc-GFP) 35 . Activated OT-I T cells uniformly expressed c-Myc-GFP as they increased in size until day 3 (Fig. 5d) . Although the activated OT-I T cells continued to proliferate and only slowly reduced in size on day 4, their expression of c-Myc-GFP was downregulated by 95% compared with that on day 2 and by 90% compared with that on day 3 (Fig. 5d,e) . In comparison, AP4 expression in wild-type cells also was upregulated following the induction of c-Myc and began to decrease on day 3 (Fig. 5d) . In contrast to the rapid decay of c-Myc, we still detected AP4 protein on day 4 (Fig. 5d,e) , which suggested that AP4 expression persisted longer than did c-Myc expression. Total RNA content per cell also was less in Tfap4 −/− OT-I T cells than in Tfap4 +/+ OT-I T cells on day 4 (Fig. 5f) . Furthermore, basal aerobic glycolysis and the maximum glycolytic capacity, as measured by the extracellular acidification rate (ECAR) 36 , were significantly lower in Tfap4 −/− OT-I cells than in Tfap4 +/+ OT-I cells recovered from the same host mice on days 4 and 6 after infection with LM-OVA (Fig. 5g) . Consistent with that, expression of genes encoding key glycolytic enzymes (normalized to a per-cell basis through the use of 'spiked-in' control RNA 37 ) was 30-60% lower and 75-80% lower in Tfap4 −/− OT-I T cells than in Tfap4 +/+ OT-I T cells on days 4 and 6 after infection, respectively (Fig. 5h) . These results indicated that AP4 was required for the sustained expression of genes encoding glycolytic molecules and suggested that AP4 sustained T cell activation after downregulation of c-Myc expression.
AP4 sustains c-Myc-initiated global cellular activity
To further define the requirement for AP4 in maintenance of the c-Myc-initiated T cell activation, we activated Tfap4 −/− and Tfap4 +/+ OT-I T cells in vivo by adoptive transfer and infection of the host with LM-OVA and analyzed gene expression by microarray at the time point at which we had detected differences in cell size. For accurate assessment of gene expression, we 'spiked' the cellular RNA with a mixture of control RNAs according to the cell number and then profiled cell number-normalized gene expression in Tfap4 −/− and Tfap4 +/+ OT-I T cells 9, 10 . Consistent with the smaller size and lower RNA content of Tfap4 −/− cells, global gene expression, as determined by the slopes of scatter plots, was lower in Tfap4 −/− OT-I cells than in Tfap4 +/+ OT-I cells (Fig. 6a,b) . We identified 1,784 genes with a difference in expression of more than 1.8-fold in Tfap4 −/− OT-I cells versus Tfap4 +/+ OT-I cells at 4 d after infection with LM-OVA ( Fig. 6a) . Pathway analysis highlighted enrichment among the group of 1,784 genes for those encoding molecules related to metabolism, transcription and translation (Fig. 6c ). To determine whether these genes were directly regulated by AP4, c-Myc or both, we performed chromatin immunoprecipitation (ChIP) analysis with antibody to AP4 (anti-AP4) and anti-c-Myc and profiled AP4-and c-Myc-bound genes in activated CD8 + T cells (Supplementary Fig. 6 ). Unbiased analysis of 7,000 statistically significant peaks of binding of AP4 or c-Myc revealed that more than 50% of the AP4 and c-Myc peaks overlapped at the gene level ( Fig. 6d) . Furthermore, nearly a quarter (479 genes) of the 1,784 genes expressed differently in Tfap4 −/− OT-I T cells versus Tfap4 +/+ OT-I T cells were bound by both AP4 and c-Myc (Fig. 6d) . The group of shared targets of AP4 and c-Myc showed considerable enrichment for genes encoding molecules categorized as being involved in metabolism, transcription and translation pathways ( Fig. 6c and Supplementary Fig. 6e ). The majority of these 479 genes were upregulated in Tfap4 +/+ OT-I cells expressing both c-Myc and AP4 on day 2 after infection of the host with LM-OVA, continued to have high expression on day 4 when c-Myc levels waned, and were eventually downregulated on day 6 following the decrease in AP4 (Fig. 6e) , which suggested that AP4 regulated these genes as c-Myc expression decayed. Because expression of these 479 genes was not different in Tfap4 −/− OT-I T cells versus Tfap4 +/+ Fig. 5h) , the altered expression of these genes on day 4 might explain the phenotypes observed in Tfap4 −/− OT-I T cells. Since we used cells coexpressing AP4 and c-Myc for the ChIP analysis, we further assessed whether AP4 still bound to these loci after downregulation of c-Myc expression by using CD25 + P14 T cells harvested from host mice 5 d after infection with LCMV-Arm. Although the expression of c-Myc was downregulated in P14 T cells on day 5 compared with its expression earlier time points (Fig. 6f) , the majority of loci previously identified as being bound by both AP4 and c-Myc retained AP4 binding (Fig. 6g) . These results suggested that c-Myc-induced AP4 expression was required for sustained transcription of c-Myc targets through direct binding. A r t i c l e s AP4 supplements c-Myc function Our data thus far suggested overlapping functions for AP4 and c-Myc in activated CD8 + T cells. To determine whether AP4 was dispensable if c-Myc expression was sustained, we retrovirally expressed a stabilized form of c-Myc (with substitution of alanine for threonine at position 58 (c-Myc(T58A)) 38, 39 ) in Tfap4 −/− OT-I T cells in a culture system that recapitulated the difference between Tfap4 −/− and wild-type cells in cell size. In this assay, we primed Tfap4 −/− and Tfap4 +/+ OT-I T cells for 2 d in vitro with anti-CD3 and anti-CD28 and subsequently cultured the cells for 24 h with irradiated splenocytes pulsed with 1 pM OVA peptide. Ectopic expression of c-Myc(T58A) or AP4 itself in Tfap4 −/− OT-I T cells 'rescued' the defects in cell size under these conditions (Fig. 7a,b) . Overexpression of c-Myc(T58A) or AP4 also restored glycolysis, incorporation of BrdU and expression of a subset of genes regulated by both AP4 and c-Myc (Fig. 7c-e) . To determine whether c-Myc(T58A) expression restored the clonal expansion of Tfap4 −/− CD8 + T cells in vivo, we transduced naive Tfap4 −/− OT-I T cells with retrovirus to express c-Myc(T58A) or AP4 and transduced Tfap4 +/+ OT-I T cells with empty retrovirus, then adoptively transferred those cells into congenic wild-type host mice, followed by infection of the hosts with LM-OVA. Although retroviral expression of AP4 in Tfap4 −/− OT-I T cells fully restored their clonal expansion and expression of the differentiation marker KLRG1, c-Myc(T58A) expression only partially restored clonal expansion ( Fig. 7f-h) . Nevertheless, c-Myc(T58A) expression increased the size and BrdU incorporation of Tfap4 −/− OT-I cells similarly to AP4 ectopic expression ( Fig. 7i,j) . These results suggested that AP4 and c-Myc had partially overlapping functions in regulating T cell activation and that a temporal switch from c-Myc to AP4 was necessary for optimal population expansion of CD8 + T cells.
To determine whether ectopic expression of AP4 correspondingly 'rescued' the defects of Myc-deficient cells, we retrovirally expressed AP4 in CD8 + T cells in which c-Myc was inducibly deleted (cells expressing a loxP-flanked allele encoding c-Myc (Myc F ) and a gene encoding Cre recombinase and a tamoxifen-inducible variant of the estrogen receptor (Cre-ER T2 ) expressed from the ubiquitously expressed Rosa26 locus (Rosa26-Cre-ER T2 )) 40, 41 . To express AP4, AP4 bound (5, 427) c-Myc bound (5, 795) A r t i c l e s we stimulated CD8 + T cells from Myc F/F Rosa26-Cre-ER T2 mice (called 'Myc −/− mice' here) and control Myc F/+ Cre − or Myc +/+ Rosa26-Cre-ER T2 mice for 24 h in vitro with anti-CD3 and anti-CD28, then infected the cells with retrovirus, followed by treatment for 2 d with 4-hydroxytamoxifen under resting conditions. Subsequently, we assessed the proliferation and gene expression of transduced cells upon restimulation with anti-CD3 and anti-CD28 (Supplementary Fig. 7a-c) . Retroviral c-Myc expression 'rescued' , albeit partially, the proliferation and size increase of Myc −/− cells (Supplementary Fig. 7d) , presumably because of a delay in expression of retrovirus-derived c-Myc compared with that of endogenous c-Myc upon restimulation (Supplementary Fig. 7c) .
In contrast, ectopic expression of AP4 failed to 'rescue' the defects of Myc −/− cells (Supplementary Fig. 7d) . Accordingly, gene-expression profiling revealed little difference between Myc −/− cells transduced with retrovirus encoding AP4-and those transduced with empty retrovirus and that transduction with retrovirus encoding c-Myc partially 'rescued' gene expression ( Supplementary Fig. 7e) . These results indicated that AP4 required prior expression of c-Myc to mediate its effects. Thus, AP4 functionally supplemented c-Myc activity to prolong the activation of CD8 + T cells.
DISCUSSION
Our study has defined a critical role for AP4 in regulating the clonal expansion and antiviral function of CD8 + T cells. AP4 regulated the maintenance but not the initiation of rapid clonal expansion after priming. AP4 was dispensable for control of infection with LCMV-Arm or LM-OVA, as clearance of these microbes occurred rapidly and full clonal expansion of antigen-specific CD8 + T cell was not necessary. In contrast, AP4 expression in CD8 + T cells was essential for protection against neurotropic infection with WNV, because control of WNV in the CNS required the sustained activity of antigen-specific CD8 + T cells. The increased susceptibility could have been due to reduced clonal expansion, leading to fewer cells' reaching the tissue (quantitative defects) or to defective differentiation as effector cells (qualitative defects). Our data suggest that AP4 is required predominantly for sustained rapid proliferation. Mechanistically, there are two main possible interpretations for the function of AP4 in regulating acute responses of CD8 + T cells. One npg A r t i c l e s interpretation is direct regulation by AP4 of genes encoding molecules essential for T cell activation. The identification of AP4-and c-Myc-bound genes in CD8 + T cells revealed a substantial overlap between targets of these two transcription factors. Combined analysis of ChIP data and gene-expression data showed that approximately a quarter of the genes expressed differently in Tfap4 −/− cells were shared binding targets of AP4 and c-Myc. Among those 1,748 genes, we specifically examined a subset encoding molecules categorized as being involved in metabolism, general transcription or translation pathways and found approximately three quarters of that subset were binding targets shared by both AP4 and c-Myc, in support of the hypothesis that AP4 contributes to maintenance of T cell activation by regulating these genes. AP4 was dispensable for initial upregulation of these genes upon T cell priming, because these pathways are initially activated by c-Myc. In contrast, after downregulation of c-Myc expression during the late phase of the acute response, the contribution of AP4 to the regulation of these genes may become critical for the maintenance of expression. AP4 bound to these loci not only in CD8 + T cells activated in vitro but also in those activated in vivo after c-Myc expression waned. In the context of cellular carbohydrate metabolism, the group of genes with different expression showed enrichment for those encoding enzymes but not transporters, which suggested the altered glucose use of Tfap4 −/− CD8 + T cells resulted from defective glycolysis rather than defective uptake of glucose. In contrast, since many genes encoding enzymes for glutaminolysis, amino acid transporters, and components of protein-translation machinery were downregulated in Tfap4 −/− CD8 + T cells, the smaller size of these cells probably reflected diminished protein synthesis resulting from defects at multiple stages. Since expression of Hif1a (which encodes the transcription factor HIF-1) and components of the mTOR pathway was not reduced, the diminished activity of the mTOR pathway may have been regulated indirectly by AP4.
As an alternative explanation, AP4 might indirectly sustain the activity of T cells through sensitizing T cell activation independently of c-Myc. Sensitivity to extrinsic stimuli might not be important for the initial activation of CD8 + T cells in the presence of abundant antigen or inflammatory cytokines. However, it may be critical in the late phase of the CD8 + T cell response in vivo due to decreases in concentrations of antigens and cytokines. Under these circumstances, Tfap4 −/− cells might prematurely lose activation, leading to their reduced metabolic activity and clonal expansion. A published study of L. monocytogenes expressing altered OVA peptide ligands has demonstrated that duration and magnitude of antigen-specific CD8 + T cell responses in vivo are determined by affinity between the TCR and peptide ligands 42 . LM-OVA strains engineered to express variant epitopes of low affinity induced less clonal expansion of OT-I T cells at the peak than did LM-OVA expressing the canonical SIINFEKL epitope, despite normal initial activation 42 . Although the reduced clonal expansion induced by low-affinity peptide ligands is similar to the diminished population expansion of CD8 + T cells in Tfap4 −/− mice, there are differences. Infection with L. monocytogenes expressing low-affinity ligands shortens the duration of clonal expansion by triggering earlier contraction and also generates reduced numbers of memory cells after clearance of the infection 42 . We observed neither of those phenotypes in Tfap4 −/− mice after infection with LM-OVA or LCMV-Arm.
Although we favor the former interpretation of AP4-dependent maintenance of c-Myc-regulated genes, the two models are not mutually exclusive. Regardless of that, our results indicate that c-Myc-induced expression of AP4 is essential for maximal clonal expansion and sustained T cell activity in a temporally regulated manner. In conclusion, our study has demonstrated that AP4 was critical for the regulation of CD8 + T cell-mediated acute antipathogen responses by sustaining, in the 'post-Myc' phase, the expression of genes encoding molecules involved in metabolism. Activated T cells used AP4 to maintain their activated states under conditions of threshold signaling for the complete elimination of pathogens.
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